- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| Fr | Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Profit Retreats In H1 | 2 | RTTNews | ||
| Fr | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
| Fr | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::CONTINUOUS RISK ASSESSMENT REPORT OF TIANJIN PHARMACEUTICAL GROUP FINANCE CO., LTD. | 1 | SGX Company Announcements | ||
| Fr | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE DEPOSIT OF NET PROCEEDS AND THE USE OF NET PROCEEDS | 1 | SGX Company Announcements | ||
| Fr | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::SECOND QUARTER AND/OR HALF YEARLY RESULTS | 1 | SGX Company Announcements | ||
| Fr | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 7TH BOARD MEETING FOR FY2026 | 3 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO A WAREHOUSING AND LOGISTICS COOPERATION AS AN INTERESTED PERSON TRANSACTION | 2 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO AN ANNUAL DISTRIBUTION AGREEMENT AS AN INTERESTED PERSON TRANSACTION | 1 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 6TH BOARD MEETING FOR FY2026 | 2 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATE BY XINXIN PHARMACEUTICAL PLANT | 3 | SGX Company Announcements | ||
| 04.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER | 1 | SGX Company Announcements | ||
| 04.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER | 2 | SGX Company Announcements | ||
| 31.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 3 | SGX Company Announcements | ||
| 31.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 11 | SGX Company Announcements | ||
| 27.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 16.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 15.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 14.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ESTIMATED RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 1 | SGX Company Announcements | ||
| 30.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 30.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::CASH DIVIDEND/DISTRIBUTION::MANDATORY | 5 | SGX Company Announcements |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 134,95 | -0,22 % | Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story? | ||
| TEVA | 31,600 | -0,63 % | Teva Pharmaceutical Industries Ltd: Moody's Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy | TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody's Ratings has upgraded Teva's corporate credit rating to Baa3... ► Artikel lesen | |
| SINOPHARM | 1,858 | +1,36 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 0,971 | +1,37 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - CHANGE OF TRUSTEE OF THE 2018 SHARE AWARD SCHEME | ||
| WUXI BIOLOGICS | 4,910 | -1,01 % | HSI Up 269 pts; HSTI Up 61 pts; LAOPU GOLD Up over 12%; LENOVO GROUP, WUXI APPTEC, TECHTRONIC IND, WUXI BIO, GENSCRIPT BIO Hit New Highs; Market Turnover Rises | ||
| OPKO HEALTH | 1,150 | -3,36 % | OPKO Health, Inc.: OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests | MIAMI, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the expansion of its financing relationship with HealthCare Royalty, a business of KKR (HCRx), through... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,816 | 0,00 % | FOSUN PHARMA Initiates Domestic Phase II Clinical Trial of FXS7553 for Pulmonary Disease Treatment | ||
| GEDEON RICHTER | 34,960 | -0,29 % | Ungarns Regierungspartei will einen Orbán-kritischen Richter als Präsidenten | ||
| DR REDDYS | 10,500 | 0,00 % | Gland Pharma share price: Stock hits 52-week high after Dr Reddy's Deepak Sapra appointed CEO | ||
| BAYER | 47,790 | -0,56 % | Bayer-Aktie schwächelt: Analysten sehen vorerst wenig Spielraum | Die Bayer-Aktie steht am Montag unter Druck und verliert rund 1,4 Prozent. Gleichzeitig sorgt eine neue Einschätzung von Jefferies für Aufmerksamkeit: Das Analysehaus bleibt bei "Hold" und sieht kurzfristig... ► Artikel lesen | |
| MERCK KGAA | 136,30 | -2,29 % | DEUTSCHE BANK RESEARCH stuft MERCK KGAA auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Merck KGaA von 125 auf 141 Euro angehoben, aber die Einstufung auf "Hold" belassen. Nach mehreren schwierigen Jahren habe sich... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 58,52 | -0,58 % | Aktien New York: Etwas schwächer - Wirtschaftsdaten versus Zinshoffnung | NEW YORK (dpa-AFX) - Am US-Aktienmarkt sind die Anleger am Freitag etwas skeptischer geworden. Dies betraf auch den Technologiesektor, der sich an den beiden Vortagen besser entwickelt hatte als Standardwerte.... ► Artikel lesen | |
| NOVO NORDISK | 39,400 | +0,09 % | 15.000 warten schon: Novo bringt Wegovy als Pille nach Deutschland - noch vor Rivale Eli Lilly | © Foto: Steffen Trumpf - dpaDie Nachfrage ist schon vor dem Start hoch. Analysten glauben jedoch, dass Eli Lilly Novo langfristig einen Großteil des Marktes abnehmen könnte.Novo Nordisk bringt seine... ► Artikel lesen | |
| APNIMED | 31,480 | -0,85 % | Apnimed, Inc.: Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) ("Apnimed"), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,245 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Successfully completed human factors validation study and pharmacokinetic study for Anaphylm (dibutepinephrine) sublingual filmRemains on track to resubmit Anaphylm NDA to the FDA in Q3 2026Continues... ► Artikel lesen |
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -1,74 % bei einem Aktienkurs von 2,260 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.